The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Association Between Estrogen Receptor α Gene Variation and Cardiovascular Disease
Abstract
CONTEXT: Estrogen and related hormone therapies activate estrogen receptors, which in turn regulate genes for several cardiovascular disease (CVD) risk factors. Relatively little is known, however, about the impact of genetic variation in estrogen receptor alpha (ESR1) on CVD risk. OBJECTIVE: To investigate whether the ESR1 c.454-397T>C polymorphism is associated with CVD risk. DESIGN, SETTING, AND PARTICIPANTS: Prospective study of 1739 unrelated men and women from the population-based offspring cohort of the Framingham Heart Study, who were followed up from 1971 to 1998. MAIN OUTCOME MEASURES: Total atherosclerotic CVD events, defined as recognized or unrecognized myocardial infarction (MI), angina pectoris, coronary insufficiency, intermittent claudication, coronary heart disease death, or atherothrombotic stroke (n = 178); major atherosclerotic CVD, defined as recognized acute MI, coronary insufficiency, coronary heart disease death, or atherothrombotic stroke (n = 83); and recognized acute MI (n = 59). RESULTS: Twenty percent of participants (n = 352) were homozygous for the ESR1 c.454-397C allele. After adjustment for covariates (age, sex, body mass index, hypertension, diabetes mellitus, total cholesterol, high-density lipoprotein cholesterol, and cigarette smoking), the CC genotype was significantly associated with major atherosclerotic CVD, with an odds ratio of 2.0 (95% confidence interval [CI], 1.3-3.2; P =.004) compared with individuals with the CT or TT genotypes. Participants with the CC genotype had 3.0-fold greater odds of MI (95% CI, 1.7-5.2; P<.001) compared with those with the CT or TT genotype. The results remained significant when analyses were restricted to men; too few women had events to study them separately. CONCLUSIONS: Individuals with the common ESR1 c.454-397CC genotype have a substantial increase in risk of MI. Whether ESR1 c.454-397T>C is causally related to MI risk or in linkage disequilibrium with 1 or more causal variants remains to be determined. These findings support the importance of estrogen receptors in CVD susceptibility, especially in men. Estrogen receptor variation also has potential to explain recent conflicting data regarding the effects of hormone therapy on CVD susceptibility in women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Zhang, J., & Yu, K. F. (1998) · JAMA · doi:10.1001/jama.280.19.1690 · Cited by 4,138
The Protective Effects of Estrogen on the Cardiovascular System
Mendelsohn, M. E., & Karas, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402306 · Cited by 3,103
Self-citationEpidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645
Genetic Susceptibility to Death from Coronary Heart Disease in a Study of Twins
Marenberg, M. E., Risch, N., Berkman, L. F., Floderus, B., & de Faire, U. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301503 · Cited by 1,255
Population stratification and spurious allelic association
Cardon, L. R., & Palmer, L. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12520-2 · Cited by 1,204
Vandenbroucke, J. P., Koster, T., Rosendaal, F. R., Briët, E., Reitsma, P. H., & Bertina, R. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90286-0 · Cited by 1,063
An Association between Atherosclerosis and Venous Thrombosis
Prandoni, P., Bilora, F., Marchiori, A., Bernardi, E., Petrobelli, F., Lensing, A. W. A., Prins, M. H., & Girolami, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022157 · Cited by 652
Waters, D. D., Alderman, E. L., Hsia, J., Howard, B. V., Cobb, F. R., Rogers, W. J., Ouyang, P., Thompson, P., Tardif, J. C., Higginson, L., et al. (2002) · JAMA · doi:10.1001/jama.288.19.2432 · Cited by 577
AN APPROACH TO LONGITUDINAL STUDIES IN A COMMUNITY: THE FRAMINGHAM STUDY
Dawber, T. R., Kannel, W. B., & Lyell, L. P. (1963) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1963.tb13299.x · Cited by 560
Abnormal Vascular Function and Hypertension in Mice Deficient in Estrogen Receptor β
Zhu, Y., Bian, Z., Lu, P., Karas, R. H., Bao, L., Cox, D., Hodgin, J., Shaul, P. W., Thorén, P., Smithies, O., et al. (2002) · Science · doi:10.1126/science.1065250 · Cited by 482
Self-citationHerrington, D. M., Howard, T. D., Hawkins, G. A., Reboussin, D. M., Xu, J., Zheng, S. L., Brosnihan, K. B., Meyers, D. A., & Bleecker, E. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012952 · Cited by 374
Estrogen Receptor-α Mediates the Protective Effects of Estrogen Against Vascular Injury
Pare, G., Krust, A., Karas, R. H., Dupont, S., Aronovitz, M., Chambon, P., & Mendelsohn, M. E. (2002) · Circulation Research · doi:10.1161/01.res.0000021114.92282.fa · Cited by 369
Self-citationHerrington, D. M., Howard, T. D., Brosnihan, K. B., McDonnell, D. P., Li, X., Hawkins, G. A., Reboussin, D. M., Xu, J., Zheng, S. L., Meyers, D. A., et al. (2002) · Circulation · doi:10.1161/01.cir.0000016173.98826.88 · Cited by 338
Genetic--epidemiologic study of early-onset ischemic heart disease.
Nora, J. J., Lortscher, R. H., Spangler, R. D., Nora, A. H., & Kimberling, W. J. (1980) · Circulation · doi:10.1161/01.cir.61.3.503 · Cited by 294
Brouchet, L., Krust, A., Dupont, S., Chambon, P., Bayard, F., & Arnal, J. F. (2001) · Circulation · doi:10.1161/01.cir.103.3.423 · Cited by 268
(1999) · Nature Genetics · doi:10.1038/8702 · Cited by 264
Yaich, L. E., Dupont, W. D., Cavener, D. R., & Parl, F. F. (1992) · PubMed · Cited by 247
Willing, M., Sowers, M., Aron, D., Clark, M. K., Burns, T., Bunten, C., Crutchfield, M., D'Agostino, D., & Jannausch, M. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.695 · Cited by 235
Sudhir, K., Chou, T. M., Chatterjee, K., Smith, E. P., Williams, T. C., Kane, J. P., Malloy, M. J., Korach, K. S., & Rubanyi, G. M. (1997) · Circulation · doi:10.1161/01.cir.96.10.3774 · Cited by 207
Becherini, L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.13.2043 · Cited by 191
Estrogen Receptor Expression and Function in Long-Term Estrogen-Deprived Human Breast Cancer Cells1
Jeng, M.-H., Shupnik, M. A., Bender, T. P., Westin, E. H., Bandyopadhyay, D., Kumar, R., Masamura, S., & Santen, R. J. (1998) · Endocrinology · doi:10.1210/endo.139.10.6229 · Cited by 175
Pendaries, C., Darblade, B., Rochaix, P., Krust, A., Chambon, P., Korach, K. S., Bayard, F., & Arnal, J.-F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042688499 · Cited by 170
Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene
Sudhir, K., Chou, T. M., Messina, L. M., Hutchison, S. J., Korach, K. S., Chatterjee, K., & Rubanyi, G. M. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63022-x · Cited by 167
Mizunuma, H., Hosoi, T., Okano, H., Soda, M., Tokizawa, T., Kagami, I., Miyamoto, S., Ibuki, Y., Inoue, S., Shiraki, M., et al. (1997) · Bone · doi:10.1016/s8756-3282(97)00178-6 · Cited by 147
Langdahl, B. L., Løkke, E., Carstens, M., Stenkjær, L. L., & Eriksen, E. F. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.11.2222 · Cited by 109
Lu, H. S., Higashikata, T., Inazu, A., Nohara, A., Yu, W., Shimizu, M., & Mabuchi, H. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000014424.18209.21 · Cited by 105
Lehtimäki, T. J., Kunnas, T. A., Mattila, K. M., Perola, M., Penttilä, A., Koivula, T. A., & Karhunen, P. J. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-001-0311-5 · Cited by 96
Deng, H., Li, J., Li, J., Johnson, M. L., Gong, G., & Recker, R. R. (1999) · Osteoporosis International · doi:10.1007/s001980050177 · Cited by 89
Kunnas, T. A. (2000) · BMJ · doi:10.1136/bmj.321.7256.273 · Cited by 84
Ferrara, A. M., Quesenberry, C. P., Karter, A. J., Njoroge, C. W., Jacobson, A. S., & Selby, J. V. (2003) · Circulation · doi:10.1161/01.cir.0000042701.17528.95 · Cited by 73
Interaction of Hemostatic Genetics With Hormone Therapy
Braunstein, J. B., Kershner, D. W., Bray, P. F., Gerstenblith, G., Schulman, S. P., Post, W. S., & Blumenthal, R. S. (2002) · CHEST Journal · doi:10.1378/chest.121.3.906 · Cited by 44
Estrogen receptor gene polymorphism and bone mineral density in postmenopausal Chinese women
Lau, E. M. C., Young, R. P., Lam, V., Li, M., & Woo, J. (2001) · Bone · doi:10.1016/s8756-3282(01)00481-1 · Cited by 28
Cited by
Estrogen receptors and human disease
Deroo, B. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27987 · Cited by 1,320
Molecular and Cellular Basis of Cardiovascular Gender Differences
Mendelsohn, M. E., & Karas, R. H. (2005) · Science · doi:10.1126/science.1112062 · Cited by 1,101
Self-citationVascular Actions of Estrogens: Functional Implications
Miller, V. M., & Duckles, S. P. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.08002 · Cited by 593
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
Corona, G., Rastrelli, G., Monami, M., Guay, A., Buvat, J., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0447 · Cited by 435
Sex differences in coronary artery disease: Pathological observations
Yahagi, K., Davis, H. R., Arbustini, E., & Virmani, R. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.017 · Cited by 310
Metadata
- Authors
- Shearman, A. M., Cupples, L. A., Demissie, S., Peter, I., Schmid, C. H., Karas, R. H., Mendelsohn, M. E., Housman, D. E., & Levy, D.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-11-05
- Volume
- 290
- Issue
- 17
- Pages
- 2263
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2095807163
- Cited by
- 277
- References
- 36
- FWCI
- 15.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.